Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
International Journal of Biological Sciences|March 17, 2020
Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathwaysXinxing Lu, Feiya Yang, Dexi Chen, et al.Cancer Management and Research|August 9, 2020
A New Surgical Technique of Combination Retroperitoneal with Transperitoneal Laparoscopic Nephroureterectomy in a Single Position and Comparative OutcomesLiming Song, Wenkuan Wang, Qinxin Zhao, et al.Acta Pharmaceutica Sinica. B|March 27, 2023
Membrane dual-targeting probes: A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detectionLing-Ling Wu, Qinxin Zhao, Qinghua Wang, et al.Andrology|December 28, 2019
Lycopene attenuates chronic prostatitis/chronic pelvic pain syndrome by inhibiting oxidative stress and inflammation via the interaction of NF-κB, MAPKs, and Nrf2 signaling pathways in ratsQinxin Zhao, Feiya Yang, Lingquan Meng, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 17, 2023
Polyphotosensitizer-Based Nanoparticles with Michael Addition Acceptors Inhibiting GST Activity and Cisplatin Deactivation for Enhanced Chemotherapy and Photodynamic ImmunotherapyQinxin Zhao, Ganghao Liang, Boda Guo, et al.Cancer Communications (London, England)|June 16, 2022
The establishment of polypeptide PSMA-targeted chimeric antigen receptor-engineered natural killer cells for castration-resistant prostate cancer and the induction of ferroptosis-related cell deathLiyuan Wu, Fei Liu, Le Yin, et al.Advanced Materials (Deerfield Beach, Fla.)|March 14, 2023
Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 for Enhanced Cancer ImmunotherapyBoda Guo, Feiya Yang, Lingpu Zhang, et al.Cancer Management and Research|July 2, 2020
Efficacy and Safety of Androgen-Deprivation Therapy Combined with Docetaxel Plus Prednisone in High-Burden Metastatic Hormone-Sensitive Prostate CancerLinjun Hu, Qinxin Zhao, Hongsong Bai, et al.Theranostics|February 28, 2020
The SIRT2-mediated deacetylation of AKR1C1 is required for suppressing its pro-metastasis function in Non-Small Cell Lung CancerHong Zhu, Yan Hu, Chenming Zeng, et al.Pageof 3